-
-
-
-
-
-
-
ResMed (RMD) PT Raised to $314 at RBC Capital
-
-
-
-
-
-
-
ResMed (RMD) PT Raised to $255 at RBC Capital, Citing 'Robust Growth And Tariff Exemptions'
-
-
-
-
-
-
-
ResMed (RMD:AU) (RMD) PT Raised to AUD35 at CLSA
-
-
-
-
-
-
-
ResMed (RMD) Tops Q2 EPS by 10c
-
-
-
-
-
-
-
ResMed (RMD) Tops Q2 EPS by 6c
-
-
-
-
-
-
-
ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
-
-
-
-
-
-
-
ResMed (RMD) Misses Q3 EPS by 10c
-
1,206,296 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

